Oncoinvent ASA
Clinical-stage biotech developing radiopharmaceutical therapies for peritoneal cancers.
OCIN | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- NO0010779341 (+1 more)
- LEI:
- 54930076H5GUZRMSNR39
- Country:
- Norway
- Address:
- Gullhaugveien 7, 0484 Oslo
- Website:
- https://www.oncoinvent.com/
- Sector:
- Manufacturing
Description
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies for cancer. The company's core focus is on direct alpha therapy, a technology platform designed to deliver potent, short-range radiation directly to cancerous tumors. Its lead product candidate, Radspherin®, is composed of inorganic microparticles that carry the alpha-emitting radionuclide Radium-224. This formulation is engineered for regional retention and slow degradation, enabling a high radiation dose to be administered within the peritoneal cavity while minimizing systemic exposure. Oncoinvent's clinical programs are primarily investigating the use of Radspherin® for treating metastatic cancers in the peritoneal cavity, including ovarian and colorectal cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-22 18:10 |
Oncoinvent ASA: Grant of share options - mandatory notification of trade - Atta…
|
English | 207.4 KB | ||
| 2025-12-22 18:10 |
Oncoinvent ASA: Grant of share options - mandatory notification of trade - Atta…
|
English | 135.0 KB | ||
| 2025-12-22 18:10 |
Oncoinvent ASA: Grant of share options - mandatory notification of trade
|
English | 6.2 KB | ||
| 2025-12-18 19:02 |
Oncoinvent ASA: Notice of Extraordinary General Meeting - Attachment: Oncoinven…
|
Norwegian | 2.3 MB | ||
| 2025-12-18 19:02 |
Oncoinvent ASA: Notice of Extraordinary General Meeting
|
English | 3.8 KB | ||
| 2025-12-10 18:15 |
Oncoinvent ASA: New share capital registered
|
English | 3.8 KB | ||
| 2025-12-08 10:49 |
Flaggemelding – Hadean Ventures AS / HVentures AB / Hadean Growth Fund I AS1 – …
|
Norwegian | 1.3 KB | ||
| 2025-12-08 07:00 |
Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ov…
|
English | 5.7 KB | ||
| 2025-12-08 06:55 |
Oncoinvent ASA: Notification of trade - primary insider/close associate - Attac…
|
English | 178.9 KB | ||
| 2025-12-08 06:55 |
Oncoinvent ASA: Notification of trade - primary insider/close associate
|
English | 4.3 KB | ||
| 2025-12-05 14:01 |
NOTIFICATION OF MAJOR HOLDINGS - Attachment: Notification of major holding Linc…
|
English | 279.4 KB | ||
| 2025-12-05 14:01 |
NOTIFICATION OF MAJOR HOLDINGS
|
English | 266 bytes | ||
| 2025-12-05 13:13 |
Oncoinvent ASA: Resolution to increase the share capital in connection with set…
|
English | 3.9 KB | ||
| 2025-12-05 13:05 |
Oncoinvent ASA: Minutes from Extraordinary General Meeting - Attachment: 2025_1…
|
Norwegian | 1.3 MB | ||
| 2025-12-05 13:05 |
Oncoinvent ASA: Minutes from Extraordinary General Meeting
|
English | 3.6 KB |
Automate Your Workflow. Get a real-time feed of all Oncoinvent ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oncoinvent ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oncoinvent ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
